Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | Mar 09, 2017 | Option Exercise | $2.12 | 33,040 | 69,959 | 51,075 | Mar 13, 2017, 04:14 PM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | Jan 20, 2016 | Option Exercise | $1.13 | 8,000 | 9,040 | 21,415 | Jan 21, 2016, 04:30 PM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | Nov 09, 2015 | Option Exercise | $2.15 | 3,785 | 8,129 | 13,600 | Nov 10, 2015, 05:04 PM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | Sep 18, 2015 | Option Exercise | $13.71 | 15,000 | 205,650 | 20,000 | Sep 22, 2015, 05:08 PM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | Jun 08, 2015 | Sale | $16.35 | 5,000 | 81,758 | 15,000 | Jun 10, 2015, 04:05 PM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | Mar 11, 2015 | Sale | $8.56 | 10,000 | 85,650 | 25,000 | Mar 12, 2015, 04:14 PM | |
CNCE | CONCERT PHARMACEUTICALS, INC. | Silverman Robert | Senior VP, General Counsel | May 29, 2014 | Option Exercise | $1.13 | 20,000 | 22,600 | 20,000 | Jun 02, 2014, 05:50 PM |